Sellgren, C M
Sheridan, S D
Gracias, J
Xuan, D
Fu, T
Perlis, R H
Article History
Received: 9 August 2016
Revised: 16 October 2016
Accepted: 18 October 2016
First Online: 13 December 2016
Competing interests
: CMS discloses lecture and consulting fees from Otsuka Pharmaceutical and H Lundbeck A/S (none of these are relevant to this work). RHP has served on scientific advisory boards or consulted to Genomind, Perfect Health, Psybrain, and RID Ventures (none of these are relevant to this work). The remaining authors declare no conflicts of interest.